Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunologyOncology Open Access | 10.1172/jci.insight.201731

STING agonism orchestrates myeloid-predominant tumor necrosis preceding T cell-dependent regression in osteosarcoma

Elizabeth P. Young,1 Christine A. Johnson,1 Alex G. Lee,1 Douglass Morris II,2 Georgia M. Edmondson,1 Alfonso G. Ramirez-Ristori,1 Jessica Tsui,3 Marcus R. Breese,4 Juan Antonio Camara Serrano,5 Courtney R. Schott,6 Clare L. Abram,7 Stanley G. Leung,8 Leanne C. Sayles,1 Aafrin M. Pettiwala,1 Vanessa S. Gutierrez Vera,9 Clifford A. Lowell,7 Alexis J. Combes,3 Troy A. McEachron,2 and E. Alejandro Sweet-Cordero1

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Young, E. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Johnson, C. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Lee, A. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Morris II, D. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Edmondson, G. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Ramirez-Ristori, A. in: PubMed | Google Scholar |

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Tsui, J. in: PubMed | Google Scholar |

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Breese, M. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Camara Serrano, J. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Schott, C. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Abram, C. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Leung, S. in: PubMed | Google Scholar |

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Sayles, L. in: PubMed | Google Scholar |

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Pettiwala, A. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Gutierrez Vera, V. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Lowell, C. in: PubMed | Google Scholar |

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Combes, A. in: PubMed | Google Scholar |

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by McEachron, T. in: PubMed | Google Scholar

1Division of Pediatric Oncology, UCSF, San Francisco, United States of America

2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America

3UCSF CoLabs, UCSF, San Francisco, United States of America

4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America

5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America

6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada

7Department of Laboratory Medicine, UCSF, San Francisco, United States of America

8Division of Radiation Oncology, UCSF, San Francisco, United States of America

9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America

10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America

Find articles by Sweet-Cordero, E. in: PubMed | Google Scholar

Published October 22, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.201731.
Copyright © 2026, Young et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published October 22, 2026 - Version history
View PDF
Abstract

An immunosuppressive, macrophage-rich tumor microenvironment (TME) is a barrier to immunotherapy across many cancers including osteosarcoma, where immunotherapy has largely failed. cGAS-STING agonism has been explored to inflame such tumors, yet the mechanisms of STING-mediated TME remodeling remain poorly understood, especially in sarcomas. Using multi-modal single cell analysis, we show that systemic STING agonism in osteosarcoma triggers a myeloid-predominant inflammatory response and rapid tumor necrosis, followed by a T cell-mediated response, immunologic memory, and long-term cure in some models. Within two hours of treatment, STING agonism induces pro-inflammatory interferon programs in tumor-associated macrophages and monocytes, with additional contributions from endothelial cells. Efficacy persists in the absence of tumor-intrinsic STING or IFNAR, confirming that the therapeutic axis resides within the host TME rather than the tumor cell compartment. While cGAS-STING is frequently repressed in human osteosarcoma models of aggressive disease, a STING activation gene signature predicts survival in newly diagnosed patients, suggesting that this pathway is engaged during tumor progression. Together, these data identify an opportunity to exploit the myeloid compartment of osteosarcoma with STING pathway therapies, charting a path forward for engaging the TME to secure long term cure in an aggressive malignancy still treated with highly toxic chemotherapy.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View TS1

View TS2

View TS3

View TS4

View

Version history
  • Version 1 (October 22, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts